Reliance on medical institutions and seasonal fluctuations in quarterly results
First written in FY2016. 17 of 21 entries say "Restated". Latest entry: FY2026.
0 other companies' latest entry also says "Other".
- FY2026Updated quarterly results for the fiscal year ending June 2026.Annual report
「Fiscal year ending June 2026 (consolidated) Fourth quarter 74,656 24.6 △142 △8.0」
For the fiscal year ending June 2026, the Company reported a fourth-quarter operating loss of ¥142 million and disclosed specific quarterly seasonal fluctuations against full-year operating income of ¥1,780 million. - FY2024Disclosure of quarterly earnings fluctuations for the fiscal year ended June 2024Annual report
「Our Group's sales are higher in the second and third quarters each year than in other periods, with earnings also tending to increase during those periods. As a result, sales toward the fourth quarter tend to be lower than in other periods, with earnings also tending to decline during that period.」
Continues to describe the seasonality of quarterly results, with an operating loss of ¥325 million in the fourth quarter and full-year operating income of ¥1,327 million for the fiscal year ended June 2024. - FY2024-Q3RestatedAnnual report
「Our Group's customers include public medical institutions such as national and municipal hospitals. Because these medical institutions tend to concentrate capital investment in December and March, which is the fiscal year-end, the Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods. As a result, sales from April to May tend to be lower than in other months, with earnings also tending to decline during that period. In addition, when a medical institution is newly built, relocated, or expanded, a large-scale bulk purchase of medical equipment may occur, temporarily increasing sales.」
Continues to describe the increase in sales and earnings in December and March due to concentrated capital investment by public medical institutions, the subsequent decline in April and May, and fluctuations caused by large-scale bulk purchases. - FY2023-Q3RestatedAnnual report
「Approximately 70% of our Group's sales are to medical institutions, including hospitals and clinics. Sales to public hospitals account for approximately 20%, and because these hospitals tend to concentrate capital investment in December and March, the Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods. As a result, sales from April to May tend to be lower than in other months, with earnings also tending to decline during that period. In addition, when a medical institution is newly built, relocated, or expanded, a large-scale bulk purchase of medical equipment may occur, temporarily increasing sales.」
Continues to describe reliance on sales to medical institutions, the concentration of capital investment in December and March, the subsequent decline in April and May, and seasonal fluctuations caused by large-scale bulk purchases. - FY2022RestatedAnnual report
「Because these medical institutions tend to concentrate capital investment in December and March, which is the fiscal year-end, our Group's sales are higher in the second and third quarters each year than in other periods, with earnings also tending to increase during those periods.」
Continues to describe the seasonal concentration of sales to medical institutions and the bias toward sales and earnings in the second and third quarters. - FY2022-Q1RestatedAnnual report
「Approximately 70% of our Group's sales are to medical institutions, including hospitals and clinics. Sales to public hospitals account for approximately 20%, and because these hospitals tend to concentrate capital investment in December and March, the Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods.」
Reiterates the Group's reliance on sales to medical institutions and the seasonal fluctuations resulting from the concentration of capital investment in December and March. - FY2021ReframedAnnual report
「Because these medical institutions tend to concentrate capital investment in December and March, which is the fiscal year-end, our Group's sales are higher in the second and third quarters each year than in other periods, with earnings also tending to increase during those periods. As a result, sales toward the fourth quarter tend to be lower than in other periods, with earnings also tending to decline during that period.」
The explanation has been reorganized from monthly seasonal concentration to a quarterly explanation of higher sales and earnings in the second and third quarters and the subsequent decline in the fourth quarter. - FY2021-Q3RestatedAnnual report
「Approximately 70% of our Group's sales are to medical institutions, including hospitals and clinics. Sales to public hospitals account for approximately 20%, and because these hospitals tend to concentrate capital investment in December and March, the Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods. As a result, sales from April to May tend to be lower than in other months, with earnings also tending to decline during that period. In addition, when a medical institution is newly built, relocated, or expanded, a large-scale bulk purchase of medical equipment may occur, temporarily increasing sales.」
Reiterates the seasonal fluctuations in sales to medical institutions, including the concentration of capital investment in December and March, the subsequent decline in April and May, and fluctuations caused by large-scale bulk purchases. - FY2020RestatedAnnual report
「Because these medical institutions tend to concentrate capital investment in December and March, which is the fiscal year-end, our Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods.」
Continues to describe the seasonal concentration of sales to medical institutions and the structure whereby quarterly results do not simply track full-year results. - FY2020-Q3RestatedAnnual report
「Approximately 70% of our Group's sales are to medical institutions, including hospitals and clinics. Sales to public hospitals account for approximately 20%, and because these hospitals tend to concentrate capital investment in December and March, the Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods. As a result, sales from April to May tend to be lower than in other months, with earnings also tending to decline during that period. In addition, when a medical institution is newly built, relocated, or expanded, a large-scale bulk purchase of medical equipment may occur, temporarily increasing sales.」
Continues to describe reliance on sales to medical institutions, seasonal concentration in December and March, the subsequent decline in April and May, and fluctuations caused by large-scale bulk purchases. - FY2019RestatedAnnual report
「Approximately 70% of our Group's sales are to medical institutions, including hospitals and clinics. Sales to public hospitals account for slightly more than 20%, and because these hospitals tend to concentrate capital investment in December and March, the Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods.」
Continues to describe fluctuations in quarterly results due to reliance on sales to medical institutions, sales to public hospitals, and seasonal concentration in December and March. - FY2019-Q3RestatedAnnual report
「Approximately 70% of our Group's sales are to medical institutions, including hospitals and clinics. Sales to public hospitals account for slightly more than 20%, and because these hospitals tend to concentrate capital investment in December and March, the Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods.」
Continues to describe fluctuations in quarterly results due to reliance on sales to medical institutions, sales to public hospitals, and seasonal concentration in December and March. - FY2019-Q2RestatedAnnual report
「Approximately 70% of our Group's sales are to medical institutions, including hospitals and clinics. Sales to public hospitals account for slightly more than 20%, and because these hospitals tend to concentrate capital investment in December and March, the Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods.」
Continues to describe fluctuations in quarterly results due to reliance on sales to medical institutions, sales to public hospitals, and seasonal concentration in December and March. - FY2019-Q1RestatedAnnual report
「Approximately 70% of our Group's sales are to medical institutions, including hospitals and clinics. Sales to public hospitals account for slightly more than 20%, and because these hospitals tend to concentrate capital investment in December and March, the Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods.」
Continues to describe reliance on sales to medical institutions, sales to public hospitals, seasonal concentration in December and March, and fluctuations in quarterly results. - FY2018RestatedAnnual report
「Approximately 70% of our Group's sales are to medical institutions, including hospitals and clinics. Sales to public hospitals account for slightly more than 20%, and because these hospitals tend to concentrate capital investment in December and March, the Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods.」
The annual report also describes reliance on sales to medical institutions, sales to public hospitals, seasonal concentration in December and March, the subsequent decline in April and May, and fluctuations caused by large-scale bulk purchases. - FY2018-Q3RestatedAnnual report
「Approximately 70% of our Group's sales are to medical institutions, including hospitals and clinics. Sales to public hospitals account for approximately 20%, and because these hospitals tend to concentrate capital investment in December and March, the Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods. As a result, sales from April to May tend to be lower than in other months, with earnings also tending to decline during that period. In addition, when a medical institution is newly built, relocated, or expanded, a large-scale bulk purchase of medical equipment may occur, temporarily increasing sales.」
Reiterates in the quarterly notes the Group's reliance on sales to medical institutions, seasonal concentration in December and March, the subsequent decline in April and May, and fluctuations caused by large-scale bulk purchases. - FY2018-Q1RestatedAnnual report
「Approximately 70% of our Group's sales are to medical institutions, including hospitals and clinics. Sales to public hospitals account for approximately 20%, and because these hospitals tend to concentrate capital investment in December and March, the Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods. As a result, sales from April to May tend to be lower than in other months, with earnings also tending to decline during that period. In addition, when a medical institution is newly built, relocated, or expanded, a large-scale bulk purchase of medical equipment may occur, temporarily increasing sales.」
Reiterates in the quarterly notes the Group's reliance on sales to medical institutions, seasonal concentration in December and March, the subsequent decline in April and May, and fluctuations caused by large-scale bulk purchases. - FY2017RestatedAnnual report
「Approximately 70% of our Group's sales are to medical institutions, including hospitals and clinics. Sales to public hospitals account for slightly more than 20%, and because these hospitals tend to concentrate capital investment in December and March, the Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods.」
The annual report also describes reliance on sales to medical institutions, sales to public hospitals, seasonal concentration in December and March, the subsequent decline in April and May, and fluctuations caused by large-scale bulk purchases. - FY2017-Q3RestatedAnnual report
「Approximately 70% of our Group's sales are to medical institutions, including hospitals and clinics. Sales to public hospitals account for approximately 20%, and because these hospitals tend to concentrate capital investment in December and March, the Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods. As a result, sales from April to May tend to be lower than in other months, with earnings also tending to decline during that period. In addition, when a medical institution is newly built, relocated, or expanded, a large-scale bulk purchase of medical equipment may occur, temporarily increasing sales.」
Continues to describe reliance on sales to medical institutions, sales to public hospitals, seasonal fluctuations in December and March, the subsequent decline in April and May, and fluctuations caused by bulk purchases. - FY2017-Q1RestatedAnnual report
「Approximately 70% of our Group's sales are to medical institutions, including hospitals and clinics. Sales to public hospitals account for approximately 20%, and because these hospitals tend to concentrate capital investment in December and March, the Group's sales are higher in December and March each year than in other months, with earnings also tending to increase during those periods.」
Also reiterates in the quarterly notes the Group's reliance on sales to medical institutions and the seasonal concentration of capital investment in December and March. - FY2016First statedAnnual report
「Approximately 70% of our Group's sales are to medical institutions, including hospitals and clinics. Sales to public hospitals account for slightly more than 20%, and because these hospitals tend to concentrate capital investment in December and March, the Group's sales are higher in December and March each year than in other months,」
Shows that approximately 70% of sales are to medical institutions and slightly more than 20% are to public hospitals, where capital investment is concentrated in December and March.